Reuters logo
BRIEF-Regis Healthcare anticipates H2 ebitda to be in line with H1
February 23, 2017 / 10:44 PM / 10 months ago

BRIEF-Regis Healthcare anticipates H2 ebitda to be in line with H1

Feb 24 (Reuters) - Regis Healthcare Ltd

* Anticipates H2 ebitda to be in line with H1 result

* Total capex spend in FY17 is anticipated to be in order of $160 MLN

* FY17 net rad inflows are anticipated to be circa $100 MLN following first half result of $46.6 MLN

* FY17 depreciation expense range is anticipated to be $28 MLN - $31 MLN, following a H1 expense of $14.2MLN

* Interest expense for FY17 is anticipated to be circa $8 MLN for full year

* Debt will remain at approximately 2X ebitda in FY2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below